NEURONTIN
BGP PHARMA ULC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of NEURONTIN in Canada?
Yes. NEURONTIN 400MG has an active shortage reported to Health Canada (last updated November 9, 2026).
Why is NEURONTIN not available?
The reason the manufacturer reported: Shortage of an active ingredient.
When will NEURONTIN be available again?
The manufacturer's estimated resolution date is January 19, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
RIVA-GABAPENTIN
LABORATOIRE RIVA INC.
Other Products
PMS-GABAPENTIN
PHARMASCIENCE INC
GABAPENTIN
SIVEM PHARMACEUTICALS ULC
AURO-GABAPENTIN
AURO PHARMA INC
PRO-GABAPENTIN
PRO DOC LIMITEE
AURO-GABAPENTIN TABLETS
AURO PHARMA INC
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2027-01-19
~2 months remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02084287
Strength
400MG
Dosage Form
CAPSULE
Route
ORAL
Active Ingredient
GABAPENTIN
Tier
Unrated
Last Updated
2026-11-09
Reason for Shortage
Shortage of an active ingredient.
Other Products from BGP PHARMA ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.